Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income
Key facts
- Who runs it
- University of Kansas Medical Center
- Where
- Kansas City, United StatesSee the site
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 36 people, planned
- Started
- 2 Mar 2026
- Planned end
- 30 Oct 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group
- Record updated
- 14 August 2026
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- English or Spanish speaking
- <13 weeks gestations
- >18 years old
- moderate or high risk for hypertensive disorders in pregnancy
Who cannot take part
- not receiving prenatal care
- no risk factors for hypertensive disorders in pregnancy
- less than18 years of age
- not eligible for doula care
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Where in United States
- University of Kansas Medical CenterKansas City, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if a telehealth hypertension group prenatal care program (Centering HER / HGPC-T) can improve blood pressure monitoring and aspirin adherence and help reduce early-onset preeclampsia in low-income, predominantly Black pregnant participants in Kansas who are <13 weeks gestation, age ≥18, and moderate or high risk for preeclampsia (USPSTF).
Read full original descriptionShow less
The main question[s] it aims to answer [is/are]:
Does Centering HER increase hypertension monitoring and aspirin compliance compared with usual doula care?
Is Centering HER feasible and acceptable, and what contextual factors influence implementation in community clinics?
The 2 groups in the trial
- usual doula care + routine prenatal carePlacebo, for comparison
Treatment: Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group
- Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual groupExisting treatment, for comparison
routine prenatal care + 7 doula-led 90-minute virtual group sessions with OB/GYN fellow oversight + Bluetooth BP cuff/scale ± Apple Watch
Treatment: Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income Black Women in Kansas
- Criteria questions
- Built from NCT07491510, who can take part
- Record updated
- 14 August 2026